Inhibition of angiogenesis by bleomycin and its copper complex.
The effects of bleomycin (BLM) and its copper complex on embryonic angiogenesis were studied in the chorioallantoic membranes of 4.5-day-old chick embryos. Copper-free BLM inhibited embryonic angiogenesis in a dose-dependent manner, with activity detectable at 1 ng/egg and maximal at 1000 ng/egg. Also, treatment with copper-BLM complex dose-dependently caused inhibition of embryonic angiogenesis in a lower dose range. Since tumor growth is believed to depend on angiogenesis, the present results may indicate that the antiangiogenic activity of BLM is, at least in part, implicated in the antitumor activity of the drug.
Oikawa
T
T
Division of Cancer Therapeutics, Tokyo Metropolitan Institute of Medical Science, Japan.
Hirotani
K
K
Ogasawara
H
H
Katayama
T
T
Ashino-Fuse
H
H
Shimamura
M
M
Iwaguchi
T
T
Nakamura
O
O
D000818:Animals; D001761:Bleomycin / Q000494:pharmacology*; D002642:Chick Embryo; D003300:Copper / Q000494:pharmacology; D009389:Neovascularization, Pathologic
D001761:Bleomycin; D003300:Copper